Blanver is a Brazilian company with more than 38 years of history marked by innovation and entrepreneurship. The experience and performance in the development, manufacture and commercialization of drugs and active pharmaceutical ingredients (APIs) made Blanver a specialist in the HIV, Hepatitis and Osteoporosis segments, offering high quality products, serving patients in Brazil through partnerships with the Ministry of Health and official laboratories. Blanver Group operations have two production plants in Brazil – one in the city of Taboão da Serra, where medicines are manufactured, and the other in Indaiatuba, for the production of APIs.
| Website | http://www.blanver.com.br |
| Revenue | $310.8 million |
| Employees | View employees |
| Founded | 1984 |
| Address | 311 Rua Herminio De Mello, Indaiatuba, Sao Paulo 13330-000, BR |
| Phone | +55 11 4138-8200 |
| Industry | Pharmaceuticals, Healthcare |
| Competitors | Roche, Novartis, AbbVie, Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb, Teva Pharmaceuticals, Mylan Belgium +47 more (view full list) |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 54171 Companies |
Looking for a particular Blanver employee's phone or email?
Blanver Questions
The Blanver annual revenue was $310.8 million in 2026.
Blanver is based in Indaiatuba, Sao Paulo.
The NAICS codes for Blanver are [5417, 541713, 541, 54, 54171].
The SIC codes for Blanver are [873, 87].
